A practical reference on Preclinical research: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-09-20 and is reviewed periodically as new material appears.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 317318-70-0 | Unique identifier for the compound. |
| Chemical class | PPARδ agonist | Synthetic ligand for peroxisome proliferator-activated receptor delta. |
| Appearance | White to off-white solid | Typical form of research-grade material. |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water. |
| Typical storage | -20°C | Recommended for long-term storage of stock solutions. |
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
The synthesis resulted in a cubic (γ-CD)6 repeating motif with a pore size of approximately 1 nm. Subsequently, in 2017 Hartlieb et al. at Northwestern did further research with CD-MOF-1 involving the encapsulation of ibuprofen. The group studied different methods of loading the MOF with ibuprofen as well as performing related bioavailability studies on the ibuprofen-loaded MOF. They investigated two different methods of loading CD-MOF-1 with ibuprofen; crystallization using the potassium salt of ibuprofen as the alkali cation source for production of the MOF, and absorption and deprotonation of the free-acid of ibuprofen into the MOF. From there the group performed in vitro and in vivo studies to determine the applicability of CD-MOF-1 as a viable delivery method for ibuprofen and other NSAIDs. In vitro studies showed no toxicity or effect on cell viability up to 100 μM. In vivo studies in mice showed the same rapid uptake of ibuprofen as the ibuprofen potassium salt control sample with a peak plasma concentration observed within 20 minutes, and the cocrystal has the added benefit of double the half-life in blood plasma samples. The increase in half-life is due to CD-MOF-1 increasing the solubility of ibuprofen compared to the pure salt form. Since these developments many groups have done further research into drug delivery with water-soluble, biocompatible MOFs involving common over-the-counter drugs.
By 1859, Cuba still did not have a Grand Lodge, and to accelerate this work, they contacted one of the most powerful figures of Freemasonry in the United States at the time, and today the most controversial figure in the history of North American Freemasonry, Albert Pike, requesting his guidance and assistance. Pike was at that time the Grand Commander of the Supreme Council of the Southern Jurisdiction of the United States for the Scottish Rite at Charleston, South Carolina.On March 26, 1859, Albert Pike gave his personal authority to the Cuban exile Andrés Cassard to create new offices, degrees, and bodies of the Scottish Rite in Cuba. However, later that year, Albert Pike and Albert Mackey also granted this authority to others in Cuba. Whether Cassard was aware of that is unclear. Four initiates from Fraternidad Lodge No. 387 joined three Cuban Freemasons living in Hudson, New York to formally petition the Grand Lodge of South Carolina to grant authority for a third Lodge. San Andres Lodge No. 93 was chartered in November 17, 1859. On November 27, 1859, the Grand Lodge of South Carolina granted a warrant to merge the three Cuban Lodges into the first Grand Lodge seen in Cuba in almost four decades; the Gran Logia de Colón (English: Grand Lodge of Columbus) at Santiago de Cuba. Under the authority Grand Lodge of Colon, the three Lodges were restructured as Fraternidad Lodge No.1, Prudencia Lodge No. 2, and San Andres Lodge No. 3. Francisco Griñán y Mozo served as the first Grand Master of the Grand Lodge of Colon.
== Epidemiology == Chronic wounds mostly affect people over the age of 60. The incidence is 0.78% of the population and the prevalence ranges from 0.18 to 0.32%. As the population ages, the number of chronic wounds is expected to rise. Ulcers that heal within 12 weeks are usually classified as acute, and longer-lasting ones as chronic.
Spinneys, which holds a 50-year lease with a 382,900 ft² cold storage distribution centre BRF (Brasil Foods), which operates a 1.6 million sq plant producing meat products and bread-based foods under the Sadia brand. Emirates Calcium Carbonate Factory, established under a 50-year agreement to supply products for oilfield industries Palletco, a manufacturing facility under a 50-year lease agreement. Apex Engineering Industries, an AED 90 million manufacturing facility for oil, gas and defence. Abundance Solar Panel Industries, an AED 55 million solar production plant. Global logistics companies, including DHL Global Forwarding and DSV, which provide logistics and supply chain services. Azizi Developments, which signed a 50-year land lease agreement to build 12 factories with an investment of AED 1 billion. Jiangsu Overseas Cooperation Investment Co. Ltd (JOCIC), established in 2017 to manage the China-UAE Industrial Capacity Cooperation Demonstration Zone. Built-to-suit
=== Mechanical properties === Crystalline cellulose has a stiffness about 140–220 GPa, comparable with that of Kevlar and better than that of glass fiber, both of which are used commercially to reinforce plastics. Films made from nanocellulose have high strength (over 200 MPa), high stiffness (around 20 GPa) but lack of high strain (12%). Its strength/weight ratio is 8 times that of stainless steel. Fibers made from nanocellulose have high strength (up to 1.57 GPa) and stiffness (up to 86 GPa).
Sources: en.wikipedia.org
Often-discussed contributing factors include feelings, emotions, life satisfaction, achievement, finding a sense of meaning, interpersonal relationships, and health. Well-being is relevant to many fields of inquiry. Positive psychology studies the factors and conditions of optimal human functioning. Philosophy examines the nature and theoretical foundations of well-being and its role as a goal of human conduct. Other related disciplines include economics, sociology, anthropology, medicine, education, politics, and religion. Although the philosophical study of well-being dates back millennia, research in the empirical sciences has intensified only since the second half of the 20th century.
== Personal life == Riff Raff has a large number of tattoos, including the logos for WorldStarHipHop, NBA, and MTV, which he had acquired during auditions for the 2009 reality TV show From G's to Gents. Previously, he had a BET tattoo on the front of his right shoulder, which was later covered up with a tattoo of his dog, "Jody Husky". He is a fan of The Simpsons, with a tattoo of Bart holding test tubes that reads "The Freestyle Scientist" on his chest. He also has a large gothic cross below his left shoulder, framed by a prayer that reads, "Dear Jesus, Please Let Me In. Your Child, Horst Simco."
Intensive insulin therapy or flexible insulin therapy is a therapeutic regimen for diabetes mellitus treatment. This newer approach contrasts with conventional insulin therapy. Rather than minimize the number of insulin injections per day (a technique which demands a rigid schedule for food and activities), the intensive approach favors flexible meal times with variable carbohydrate as well as flexible physical activities. The trade-off is the increase from 2 or 3 injections per day to 4 or more injections per day, which was considered "intensive" relative to the older approach. In North America in 2004, many endocrinologists prefer the term "flexible insulin therapy" (FIT) to "intensive therapy" and use it to refer to any method of replacing insulin that attempts to mimic the pattern of small continuous basal insulin secretion of a working pancreas combined with larger insulin secretions at mealtimes. The semantic distinction reflects changing treatment.
=== Fungal === In the fungus Neurospora crassa, four different forms of tyrosinase were distinguished among different strains. In each strain only one structure-determining genetic region was found for the enzyme.
Sources: en.wikipedia.org
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.
No. Cardarine is not an anabolic steroid; it belongs to a different chemical class that targets PPARδ. Steroids act primarily through androgen receptors, while cardarine acts through a nuclear receptor involved in metabolism.
Some rodent studies reported increased endurance and changes in fat metabolism after cardarine exposure. Long-term studies in animals also raised concerns about cancer in certain tissues. Human trial data are limited, so these findings cannot be directly translated to people.
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.